Skip to main navigation Skip to search Skip to main content

At last, a noninjectable adrenaline device for anaphylaxis management

  • Campbelltown Hospital

Research output: Contribution to journal › Article › peer-review

Abstract

A needle-free adrenaline nasal spray is now TGA approved for the emergency treatment of anaphylaxis. The new formulation is likely to improve compliance with instructions to administer adrenaline promptly in the event of a severe allergic reaction.

Original languageEnglish
Pages (from-to)33-34
Number of pages2
JournalMedicine Today
Volume27
Issue number1-2
Publication statusPublished - 2026

Fingerprint

Dive into the research topics of 'At last, a noninjectable adrenaline device for anaphylaxis management'. Together they form a unique fingerprint.

Cite this